Toti-N-glycan recognition enables universal multiplexed single-nucleus RNA sequencing
ResearchPeer-Reviewed Publication
The rapid advancement of single-cell and single-nucleus RNA sequencing (sc/snRNA-seq) has opened unprecedented windows into cellular diversity, yet existing methods for multiplexing samples struggle with scalability and accuracy. Traditional techniques relying on antibodies or lipid-based barcodes often fail to uniformly label cells across different types or species, particularly in complex clinical samples. These limitations—cell-type bias, cross-contamination risks, and loss of rare cell populations—hinder large-scale studies and clinical translation. To overcome these challenges, a team led by Professor Yiwei Li at Huazhong University of Science and Technology (HUST) has pioneered Toti-N-Seq, a groundbreaking technology that harnesses the universal presence of N-glycans on cell and nuclear surfaces. Published as a cover story in Research (2025, DOI: 10.34133/research.0678), this innovation redefines how researchers approach high-throughput cellular profiling.
- Journal
- Research
- Funder
- National Key Research and Development Program of China, National Natural Science Foundation of China, Fundamental Research Funds for Central Universities, HUST